Peripartum Cardiomyopathy
Peripartum cardiomyopathy is defined as a dilated cardiomyopathy with congestive heart failure within the last month of pregnancy or within 5 months of delivery.8 This condition occurs at a rate of 1 in 2,289 live births and risk factors are multiparity, advanced maternal age, preeclampsia, gestational hypertension, and African descent. Some studies show a 75% recovery rate to normal ventricular function.9 Animal studies have suggested that a prolactin metabolite associated with peripartum cardiomyopathy can be cardiotoxic and that treatment with bromocriptine may be beneficial.10 Although the cause is not well understood, the treatment remains similar to that for congestive heart failure patients in general.
Peripartum CardiomyopathyPeripartum cardiomyopathy is defined as a dilated cardiomyopathy with congestive heart failure within the last month of pregnancy or within 5 months of delivery.8 This condition occurs at a rate of 1 in 2,289 live births and risk factors are multiparity, advanced maternal age, preeclampsia, gestational hypertension, and African descent. Some studies show a 75% recovery rate to normal ventricular function.9 Animal studies have suggested that a prolactin metabolite associated with peripartum cardiomyopathy can be cardiotoxic and that treatment with bromocriptine may be beneficial.10 Although the cause is not well understood, the treatment remains similar to that for congestive heart failure patients in general.
การแปล กรุณารอสักครู่..